Hollstein M. , Sidransky D., Vogelstein B., and Harris CC (1991). p53 mutations in human cancers. Science253: 49-53.
2.
Marletta MA (1993). Nitric oxide synthase structure and mechanism . J. Biol. Chem. 268: 12231-12234.
3.
Nguyen T., Brunson D., Crespi CL, Penman BW, Wishnok JS, and Tannenbaum SR (1992). DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA89: 3030-3034.
4.
Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M., Dunams TM, Cebula TA, Koch WH, Andes AW, Allen JS, and Keefer LK (1991). DNA deaminating ability and genotoxicity of nitric oxide and its progenators. Science254: 1001-1003.
5.
Balmain A. and Brown K. (1988). Oncogene activation in chemical carcinogenesis . Adv. Cancer Res. 51: 147-182.
DiGiovanni J. (1992). Multistage carcinogenesis in mouse skin. Pharmacol. Ther. 54: 63-128.
8.
Hollstein M. , Sidransky D., Vogelstein B., and Harris CC (1991). p53 mutations in human cancers. Science253: 49-53.
9.
Kern SE, Pietenpol JA, Thiagalingam S., Seymour A., Kinzler KW, and Vogelstein B. (1992). Oncogenic forms of p53 inhibit p53-regulated gene expression. Science256: 827-830.
10.
Milner J. and Medcalf EA (1991). Cotranslation of activated mutant p53 with wild type p53 protein drives the wild-type protein into the mutant conformation . Cell65: 765-774.
11.
Vogelstein B. and Kinzler KW (1992). p53 function and dysfunction . Cell70: 523-526.
12.
Amstad P., Peskin A., Shah G., Mirault ME, Moret R., Zbinden I., and Cerutti P. (1991). The balance between Cu, Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry30: 9305-9313.
13.
Cerutti P., Shah G., Peskin A., and Amstad P. (1992). Oxidant carcinogenesis and antioxidant defense . Ann. N. Y. Acad. Sci. 663: 158-166.
14.
Jain PT, Berezesky IK, and Trump BF (1992). Differential effects of promoters on [Ca2+]i in promotable (Clone 41) and non-promotable (Clone 30) JB6 mouse keratinocytes . Proc. Am. Assoc. Cancer Res. 33: 30.
15.
Jain PT, Fitzpatrick MJ, Phelps PC, Berezesky IK, and Trump BF (1992). Studies of skin toxicity in vitro: Dose-response studies on JB6 cells. Toxicol. Pathol. 20: 394-404.
16.
Trump BF, Jain PT, Phelps PC, Chang SH, and Berezesky IK (1993). Calcium measurements in the assessment of in vitro toxicity. In: In Vitro Toxicology Mechanism and New Technology (Alternative Methods in Toxicology Series), Vol. 9, AM Goldberg (ed). Mary Ann Liebert, Inc., Publishers , New York, pp. 175-184.
17.
Cerutti PA and Trump BF (1991). Inflammation and oxidative stress in carcinogenesis . Cancer Cells3: 1-7.
18.
Houghton PJ, Bailey FC, Germain GS, Grindey GB, Witt BC, and Houghton JA (1990). N-(5-Indanylsulfonyl)-N'-(4-chlorophenyl)urea, a novel agent equally cytotoxic to nonproliferating human colon adenocarcinoma cells. Cancer Res. 50: 318-322.
19.
Maki A., Berezesky IK, Fargnoli J., Holbrook NJ, and Trump BF (1992). Role of [Ca2+]i in induction of c-fos, c-jun, and c-myc mRNA in rat PTE after oxidative stress. FASEB J . 6: 919-924.
20.
Trump BF and Berezesky IK (1992). The role of cytosolic Ca2+ in cell injury, necrosis, and apoptosis. Curr. Opin. Cell Biol. 4: 227-232.
21.
Yamamoto N., Maki A., Swann JD, Berezesky IK, and Trump BF (1993). Induction of immediate early and stress genes in rat proximal tubule epithelium following injury: The significance of cytosolic ionized calcium. Renal Failure15(2): 165-174.
22.
Beach AC, Agarwai SC, Lambert GR, Nesnow S., and Gupta RC (1993). Reaction of cyclopenta[cd]pyrene-3,4-epoxide with DNA and deoxynucleotides. Carcinogenesis14: 767-771.
23.
Busby WE, Stevens ER, Kellerbach ER, Cornelise J., and Lugtenberg J. (1988). Dose-response relationships of the tumorigenicity of cyclopenta[cd]pyrene, benzo[a]pyrene and 6-nitrochrysene in a newborn mouse lung adenoma assay. Carcinogenesis9: 741-746.
24.
Gold A., Nesnow S., Moore-Brown M., Garland H., Cur-tis G., Howard B., Graham D., and Eisenstadt E. (1980). Mutagenesis and morphological transformation of mammalian cells by a non-Bay Region polycyclic cyclopenta[cd]pyrene and its 3,4-oxide. Cancer Res.41: 1893-1897.
25.
International Agency for Research on Cancer (1983). Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man, Polynuclear Aromatic Compounds, Part 1, Chemical, Environmental and Experimental Data, Vol 32, pp. 147-153, International Agency for Research on Cancer, Lyon, France.
26.
Mass MJ, Jeffers AJ, Ross JA, Nelson G., Galati AJ, Stoner GD, and Nesnow S. (1993). K-ras oncogene mutations in tumors and DNA-adducts formed by benz[j]aceanthrylene and benzo[a]pyrene in the lungs of strain A/J mice. Molec. Carcinogen. 8: 186-192.
27.
Ahmed N. and Saffiotti U. (1992). Crystalline silica-induced cytotoxicity, transformation, chromosomal translocations and oncogene expression. Proc. Amer. Assoc. Cancer Res. 33: 119.
28.
Daniel LN, Mao Y., and Saffiotti U. (1993). Oxidative DNA damage by crystalline silica. Free Radical Biol. Med. 14: 463-472.
29.
Mao Y., Daniel LN, Whittaker N., and Saffiotti U. (1993). DNA binding to crystalline silica characterized by Fourier-transform infrared spectroscopy. Anal. Biochem. (in press).
30.
Saffiotti U. (1992). Lung cancer induction by crystalline silica. Progr. Clin. Biol. Res. 374: 51-69.
31.
Saffiotti U. , Kaighn ME, Knapton AD, and Williams AO (1993). Transformation of the fetal rat lung alveolar Type II cell line, FRLE, by lipofection with a mutated K-ras gene. Proc. Amer. Assoc. Cancer Res. 34: 102.
32.
Williams AO, Flanders KC, and Saffiotti U. (1993). Immunohistochemical localization of transforming growth factor-β in rats with experimental silicosis, alveolar Type II hyperplasia and lung cancer. Am. J. Pathol. 142: 1831-1840.
33.
Harris CC (1989). Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair. Carcinogenesis10: 1563-1566.
34.
Hayashi SI, Watanabe J., and Kawajiri K. (1992). High susceptibility to lung cancer in terms of combined genotypes of P4501A1 and Mu-class glutathione S-transferase genes. Jpn. J. Cancer Res. 83: 866-870.
35.
Seidegard J. , Pero RW, Markowitz MM, Roush G., Miller DG, and Beattie EJ (1990). Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: A follow up study. Carcinogenesis11: 33-36.
36.
Shields PG and Harris CC (1991). Molecular epidemiology and the genetics of environmental cancer. JAMA266: 681-687.
37.
Fujimoto K., Yamada Y., Okajima E., Kakizoe T., Sasaki H., Sugimura T., and Terada M. (1992). Frequent association of p53 gene mutations in invasive bladder cancer. Cancer Res. 52: 1393-1398.
38.
Hollstein M. , Sidransky D., Vogelstein B., and Harris CC (1991). p53 mutations in human cancers. Science253: 49-53.
39.
Lasko DD, Harvey SC, Malaikal SB, Kadlubar FF, and Essigmann JM (1988). Specificity of mutagenesis by 4-aminobiphenyl. A possible role for N-(deoxyadenosin-8-yl)-4-aminobiphenyl as a premutational lesion. J. Biol. Chem. 263: 15429-15435.
40.
Sidransky D. , Von Eschenbach A., Tsai YC, Jones P., Summerhayes I., Marshall F., Paul M., Green P., Hamilton SR, Frost P., and Vogelstein B. (1991). Identification of p53 gene mutations in bladder cancers and urine samples . Science252: 706-709.
41.
Grunstein M. (1990). Nucleosomes: Regulators of transcription. Trends Genet. 6: 395-400.
42.
Taylor ICA , Workman JL, Schuetz TJ, and Kingston RE (1991). Facilitated binding of GAL4 and heat shock factor to nucleosomal templates: Differential function of DNA-binding domains. Genes Dev. 5: 1285-1298.
43.
Wechsler DS and Dang CV (1992). Opposite orientations of DNA bending by c-Myc and Max. Proc. Natl. Acad. Sci. USA89: 7635-7639.
44.
Wolffe AP (1992). New insights into chromatin function in transcriptional control. FASEB J. 6: 3354-3361.
45.
Brash DE, Rudolph JA, Simon JA, Lin A., McKenna GJ, Baden HP, Halperin AJ, and Ponten J. (1991). A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA88: 10124-10128.
46.
Bums PA, Kemp CJ, Gannon JV, Lane DP, Bremner R., and Balmain A. (1991). Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice. Oncogene6: 2363-2369.
47.
Donehower LA , Harvey M., Slagle BL, McArthur MJ, Montgomery CA, Butel JS, and Bradley A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (London)356: 215-221.
48.
Kem SE, Pietenpol JA, Thiagalingam S., Seymour A., Kinzler KW, and Vogenstein B. (1992). Oncogenic forms of p53 inhibit p53-regulated gene expression. Science256: 827-830.
49.
Ruggeri B., DiRado M., Zhang SY, Bauer B., Goodrow T., and Klein-Szanto AJP (1993). Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. Proc. Natl. Acad. Sci. USA90: 1013-1017.
50.
Omenn GS, Goodman G., Thornquist M., Grizzle J., Rosenstock L., Barnhart S., Balmes J., Chemiack M., Cullen M., Glass A., Keogh J., Meyskens F. Jr, Valanis B., and Williams J. Jr (1993). The Beta-Carotene and Retinol Efficacy Trial (CARET) for chemoprevention of lung cancer in high-risk populations: Smokers and asbestos-exposed workers. Cancer Res. (in press).
51.
Thornquist MD , Omenn GS, Goodman GE, Grizzle JE, Rosenstock L., Barnhart S., Anderson GL, Hammar S., Balmes J., Cherniack M., Cone J., Cullen MR, Glass A., Keogh JP, Meyskens F. Jr, Valanis B., and Williams JH Jr (1993). Statistical design and monitoring of the Carotene and Retinol Efficacy Trial (CARET). Controlled Clin. Trials (in press).
52.
Bishop JM (1991). Molecular themes in oncogenesis. Cell64: 235-248.
53.
Cantley LC, Auger KR, Carpenter C., Duckworth B., Graziani A., Kapeller R., and Soltoff S. ( 1991 ). Oncogenes and signal transduction. Cell61: 281-302.
54.
Eilers M., Schirm S., and Bishop JM (1991). The MYC protein activates transcription of the α-prothymosin gene. EMBO J. 10: 133-141.
55.
Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H., Brooks M., Waters EM, Penn LZ, and Hancock DC (1992). Induction of apoptosis in fibroblasts by c-myc protein. Cell69: 119-128.
56.
McCormick F. (1993). How receptors turn Ras on. Nature (London)363: 15-16.
57.
Nishida E. and Gotoh Y. (1993). The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biol. Sci. 18: 128-131.
58.
Gonzalez FJ (1992). Human cytochromes P450: Problems and prospects . Trends Pharmacol. Sci. 13: 346-352.
59.
Gonzalez FJ and Nebert DW (1990). Evolution of the P450 gene superfamily: Animal plant "warfare", molecular drive and human genetic differences in drug oxidation . Trends Genet. 6 : 182-187.
60.
Idle JR, Armstrong M., Boddy AC, et al (1992). The pharmacogenetics of chemical carcinogenesis . Pharmacogenetics2: 246-258.
61.
Abrahamson S. , Bender C., Conger A., and Wolff S. (1973). Uniformity of radiation induced mutation rates among different species. Nature (London)245(5426): 460-462.
62.
Brewen JG, Preston RJ, Jones KP, and Gosslee DG (1973). Genetic hazards of ionizing radiations: Cytogenetic extrapolations from mouse to man. Mutat. Res. 17: 245-254.
63.
Kohler SW, Provost GS, Fieck A., Kretz PL, Bullock WO, Putman DL, Sorge JA, and Short JM (1991). Analysis of spontaneous and induced mutations in transgenic mice using a lambda ZAP/LacI shuttle vector. Env. Molec. Mutagen. 18: 316-321.
64.
Leonard A., Decat G., and Fabry L. (1982). The lymphocytes of small mammals: A model for research in cytogenetics? Mutat. Res. 95: 31-44.
65.
Loeb AL (1991). Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51: 3075-3079.
66.
Mendelsohn ML (1990). The somatic mutational component of human carcinogenesis. In: Scientific Issues in Quantitative Cancer Risk Assessment, S Moolgavkar (ed). Birkhauser, Boston, pp. 22-31.
67.
Mendelsohn ML , Moore DH Jr, and Lohman PHM (1992). A method for comparing and combining short-term genotoxicity test data: Results and interpretation . Mutat. Res. 266: 43-60.
68.
Myhr BC (1991). Validation studies with Muta mouse: A transgenic mouse model for detecting mutations in vivo. Env. Molec. Mutagen . 18: 308-315.
69.
Rhomberg L., Dellarco VL, Siegel-Scott C., Dearfield KL, and Jacobson-Kram D. (1990). Quantitative estimation of the genetic risk associated with the induction of heritable translocations at low-dose exposure: Ethylene oxide as an example. Env. Molec. Mutagen. 16: 104-125.
70.
Thacker J. (1992). Radiation-induced mutation in mammalian cells at low doses and dose rates. Adv. Rad. Biol. 16: 77-124.
71.
Eker R. and Mossige J. (1961). A dominant gene for renal adenomas in the rat . Nature (London)189: 858-859.
72.
Funaki K., Everitt J., Bermudez E., and Walker C. ( 1991 ). Trisomy of rat chromosome 1 associated with mesothelial cell transformation. Cancer Res. 51: 4059-4066.
73.
Funaki K., Everitt J., Oshimura M., Freed JJ, Knudson AG, and Walker C. (1991). Hereditary renal cell carcinoma in the rat associated with nonrandom loss of chromosomes 5 and 6. Cancer Res. 51: 4415-4422.
74.
Gerwin BI, Lechner JF, Reddel RR, Roberts AB, Robbins KC, Gabrielson EW, and Harris CC (1987). Comparison of production of transforming growth factor-b and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res. 47: 6180-6184.
75.
Klein-Szanto AJp, Anderson MW, Barrett JC, and Slaga TJ (eds) (1992). Comparative Molecular Carcinogenesis from Progress in Clinical and Biological Research . John Wiley & Sons Press, New York.
76.
Walker C., Bermudez E., Stewart W., Bonner J., Molloy CJ, and Everitt J. (1992). Characterization of platelet-derived growth factor and platelet-derived growth factor receptor expression in asbestos-induced rat mesothelioma. Cancer Res. 52: 301-306.
77.
Walker C., Recio L., Funaki K., and Everitt J. (1992). Cytogenetic and molecular correlates between rodent and human renal cell carcinoma. Prog. Clin. Biol. Res. 376: 289-302.
78.
Coleman WB, Wennerberg AE, Smith GJ, and Grisham JW (1993). Regulation of differentiation of diploid and some aneuploid rat liver epithelial (stemlike) cells by the hepatic microenvironment . Am. J. Pathol. 142 : 1373-1382.
79.
Lee LW, Raymond VW, Tsao M.-S, Lee DC, Earp HS, and Grisham JW (1991). Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor-α genes in chemically transformed rat liver epithelial cells. Cancer Res. 51: 5238-5244.
80.
Levan G., Szpirer J., Szpirer C., Klinga K., Hanson C., and Islam MQ (1991). The gene map of the Norway rat (Rattus norvegicus) and comparative mapping with mouse and man. Genomics10: 699-718.
81.
Steadman JS, Lee LW, Smith GJ, and Grisham JW (1994). DNA contents and chromosomes of transformed rat liver epithelial cells and of cells of their derived tumors. Cancer Res. (in press).
82.
Takahashi K. , Kudo J., Ishibashi H., Hirata Y., and Niho Y. (1993). Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma . Hepatology17: 794-799.
83.
Tsao M-S. and Grisham JW (1987). Hepatocarcinomas, cholangiocarcinomas, and hepatoblastomas produced by chemically transformed cultured rat liver epithelial cells. A light and electron microscopic study. Am. J. Pathol. 127: 168-181.
84.
Yeh YC, Tsai J.-F., Chuang L.-Y., Yeh H.-W., Tsai J.-H., Florine DL, and Tam JP (1987). Elevation of transforming growth factor α and its relationship to the epidermal growth factor and α-fetoprotein levels in patients with hepatocellular cancer. Cancer Res . 47: 896-901.
85.
Aguilar F., Hussain P., and Cerutti P. (1993). Aflatoxin B 1 induces the transversion of G to T in codon 249 of the human p53 tumor suppressor gene in human hepatocytes . Proc. Natl. Acad. Sci. USA90: 8586-8590.
86.
Felley-Bosco E., Pourzand C., Zijlstra J., Amstad P., and Cerutti P. (1991). A genotypic mutation system measuring mutations in restriction recognition sequences. Nucl. Acids Res.19: 2913-2919.
87.
Pourzand C. and Cerutti P. (1993). Genotypic mutation analysis by RFLP/PCR. Mutat . Res. 288: 113-121.
88.
Sandy M., Chiocca S., and Cerutti P. (1992). Genotypic analysis of mutations in Taq I restriction recognition sites by restriction fragment length polymorphism/ polymerase chain reaction. Proc. Natl. Acad. Sci. USA89: 890-894.
89.
Zijlstra J., Felley-Bosco E., Amstad P., and Cerutti P. (1990). A mammalian mutation system avoiding phenotypic selection: The RFLP/PCR approach. In: Mutagens in the DietM Pariza and HU Aeschbacher (eds). Wiley-Liss, New York, pp. 187-200.
90.
Bishop JM (1991). Molecular themes in oncogenesis. Cell64: 235-248.
91.
Fearon ER and Vogelstein B. (1990). A genetic model for colorectal tumorigensis. Cell61: 709-767.
92.
Sidransky D. , Boyle JO, and Koch W. (1993). Molecular screening: Prospects for a new approach. Arch. Oto. Head Neck Surg. 119: 1187-1190.
93.
Sidransky D. , Tokino T., Hamilton SR, Kinzler KW, Levin B., Frost P., and Vogelstein B. (1992). Identification of ras oncogene mutations in the stool of patients with curable colorectal tumor. Science256: 102-105.
94.
Sidransky D. , Von Eschenbach A., Tsai YC, Jones P., Summerhayes I., Marshall F., Paul M., Green P., Hamilton SR, Frost P., and Vogelstein B. (1991). Identification of p53 gene mutations in bladder cancers and urine samples . Science252: 706-709.
95.
Weinberg RA (1991). Tumor suppressor genes. Science254:1138.
96.
Butler MA, Lang NP, Young JF, Caporaso NE, Vineis P., Hayes RB, Teitel CH, Massengill JP, Lawsen MF, and Kadlubar FF (1992). Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics2: 116-127.
97.
Grant DM, Blum M., and Meyer UA (1992). Polymorphisms of N-acetyltransferase genes. Xenoniotica22: 1073-1081.
98.
Guengerich FP and Shimada T. (1991). Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Tox. 4: 319-407.
99.
Kadlubar FF, Butler MA, Kaderlik KR, Chou H-C., and Lang NP (1992). Polymorphisms for carcinogen metabolism in humans: Relevance for human carcinogenesis. Environ. Health Persp . 98: 69-74.
100.
Kadlubar FF, Dooley KL, Teitel CH, Roberts DW, Benson RW, Butler MA, Bailey JR, Young JF, Skipper PW, and Tannenbaum SR (1991). Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl . Cancer Res. 51: 4371-4377.
101.
Ketterer B., Harris JM, Talaska G., Meyer DJ, Pemble SE, Taylor JB, Lang NP, and Kadlubar FF (1992). The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer . Environ. Health Persp. 98: 87-94.
102.
Turesky RJ, Lang NP, Butler MA, Teitel CH, and Kadlubar FF (1991). Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis12: 1839-1845.
103.
Beland FA and Poirier MC (1993). Significance of DNA adduct studies in animal models for cancer molecular dosimetry and risk assessment. Environ. Health Perspect. 99: 5-10.
104.
Skipper PL and Tannenbaum SR (1990). Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis11: 507-518.
105.
Swenberg JA, Fedtke N., Fennell TR, and Walker VE (1990). Relationships between carcinogen exposure, DNA adducts and carcinogenesis. In: Progress in Predictive Toxicology , DB Clayson, IC Monro, P Shubik, and JA Swenberg (eds). Elsevier, Amsterdam, pp. 161-184.
106.
Walker VE, Fennell TR, Upton PB, MacNeela JP, and Swenberg JA (1993). Molecular dosimetry of DNA and hemoglobin adducts in mice and rats exposed to ethylene oxide. Environ. Health Perspect. 99: 11-17.
107.
United States Environmental Protection Agency (1986). The Risk Assessment Guidelines of 1986. EPA/600/8-87/045. Office of Health and Environmental Assessment, Washington, DC.
108.
Finch L. and Frederick CB (1992). Rate and route of oxidation of acrylic acid to carbon dioxide in rat liver. Fund. Appl. Toxicol. 19: 498-504.
109.
Frederick CB , Potter DW, Chang-Mateu MI, and Anderson ME (1992). A physiologically based pharmacokinetic and pharmacodynamic model to describe the oral dosing of rats with ethyl acrylate and its implications for risk assessment. Toxicol. Appl. Pharmacol. 114: 246-260.
110.
Schweitzer B. and Philippsen P. (1991). CDC15, an essential cell cycle gene in Saccharomyces cerevisiae, encodes a protein kinase domain. Yeast7: 265-273.
111.
Spevak W., Keiper BD, Stratowa C., and Castanon MJ (1993). Saccharomyces cerevisiae CDC15 mutants arrested at a late stage in anaphase are rescued by Xenopus cDNAs encoding N-ras or a protein with β-transducin repeats. Mol. Cell. Biol. 13: 4953-4966.
112.
Sulston JE, Schierenberg E., Ghetto JG, and Thomson JN (1983). The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev. Biol. 100: 64-11 g.
113.
Bernstein LR and Colburn NH (1989). AP1/jun function is differentially induced in promotion sensitive and resistant JB6 cells. Science244: 566-569.
114.
Sun Y., Pommier Y., and Colburn NH (1992). Acquisition of a growth inhibitory response to phorbol ester involves DNA damage. Cancer Res. 52: 1907-1915.
115.
Hengartner MO , Ellis RE, and Horvitz HR (1992). Caenorhabditis elegans gene ced-9 protects cells from programmed cell death . Nature (London)356: 494-499.
116.
Maki A., Berezesky IK, Fargnoli J., Holbrook NJ, and Trump BF( 1992). Role of [Ca2+]i in induction of c-fos, c-jun, and c-myc mRNA in rat PTE after oxidative stress. FASEB J. 6: 919-924.
117.
Ohmori T., et al (1993). Apoptosis of lung cancer cells caused by some anti-cancer agents (CMMC, CPT-11, ADM) is inhibited by bcl-2. Biochem. Biophys. Res. Commun. 15: 30-36.
118.
Smeyne RJ, et al (1993). Continuous c-fos expression precedes programmed cell death in vivo. Nature (London)363: 166-169.
119.
Trump BF and Berezesky IK (1992). The role of cytosolic Ca2+ in cell injury, necrosis, and apoptosis. Curr. Opin. Cell Biol. 4: 227-232.
120.
Trump BF, Berezesky IK, and Smith MA (1993). Cellular calcium and mitochondrial dysfunction . In: Methods in Toxicology: Mitochondrial Dysfunction, Vol. 2, Chap. 28, DP Jones and LH Lash (eds). Academic Press. London, New York, pp. 337-353.
121.
Trump BF and Ginn FL (1969). The pathogenesis of subcellular reaction to lethal injury. In: Methods and Achievements in Experimental Pathology, Vol. IV, E Bajusz and G Jasmin (eds). Karger, Basel, pp. 1-29.
122.
Yamamoto N., Maki A., Swann JD, Berezesky IK, and Trump BF (1993). Induction of immediate early and stress genes in rat proximal tubule epithelium following injury: The significance of cytosolic ionized calcium. Ren. Fail. 15(2): 163-171.